{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:43:32Z","timestamp":1785545012783,"version":"3.56.0"},"reference-count":32,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Cardio"],"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n Patients hospitalized for heart failure (HF) face a high-risk early postdischarge period.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n We aimed to develop and internally validate the soluble ST2, age, and estimated glomerular filtration rate\u2013heart failure (SAGE-HF) score, a simplified risk model incorporating soluble suppression of tumorigenicity 2 (sST2), age, and renal function, for predicting 30-day postdischarge major adverse cardiovascular events (MACE).<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n This two-center prospective cohort study included 218 patients hospitalized with acute decompensated heart failure (ADHF) and\/or heart failure with reduced ejection fraction (HFrEF) and 59 non-HF controls in Vietnam (July 2025-January 2026). Serum sST2 concentrations were measured at admission using enzyme-linked immunosorbent assay and compared between the ADHF\/HFrEF cohort and controls, with adjustment for clinical covariates. Among the ADHF\/HFrEF cohort, the primary endpoint was 30-day MACE, defined as a composite of all-cause death or HF rehospitalization. Candidate predictors were considered based on clinical relevance, biological plausibility, and exploratory univariable associations, and prespecified parsimonious logistic regression models were evaluated using discrimination (area under the receiver operating characteristic curve [AUC]), calibration, Brier score, and Akaike information criterion. Internal validation was performed using 1000 bootstrap resamples, and model robustness was assessed using Firth penalized logistic regression. The SAGE-HF score was derived from the final model. All data were analyzed using the R environment (version 4.5.5; R Foundation for Statistical Computing).<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Among 277 participants, sST2 concentrations were significantly higher in patients with HF than in non-HF controls after adjustment. Among 218 patients, 47 (21.6%) experienced 30-day MACE. In multivariable analysis, age (odds ratio [OR] 1.04 per year, 95% CI 1.01\u20101.07;\n P<\/jats:italic>\n =.02), sST2 (OR 1.06 per ng\/mL, 95% CI 1.01\u20101.11;\n P<\/jats:italic>\n =.01), and estimated glomerular filtration rate (OR 0.98 per unit, 95% CI 0.97\u20101.00;\n P<\/jats:italic>\n =.02) were independently associated with MACE. The final model demonstrated acceptable discrimination (AUC 0.741, 95% CI 0.664\u20100.819) and good calibration, with stable performance after bootstrap validation (corrected AUC 0.725). Firth analysis yielded consistent results. The SAGE-HF score showed progressive risk stratification, with predicted 30-day MACE ranging from 7.0% to 60.1% and maintained acceptable discrimination and calibration.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n The SAGE-HF score, incorporating age, sST2, and estimated glomerular filtration rate, demonstrated acceptable performance for predicting 30-day MACE after HF hospitalization and may support early risk stratification, pending external validation.<\/jats:p>\n <\/jats:sec>","DOI":"10.2196\/97879","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T17:19:16Z","timestamp":1785345556000},"page":"e97879-e97879","source":"Crossref","is-referenced-by-count":0,"title":["Development and Internal Validation of the Soluble ST2, Age, and Estimated Glomerular Filtration Rate\u2013Heart Failure Score for Predicting 30-Day Major Adverse Cardiovascular Events After Heart Failure Hospitalization in a Two-Center Vietnamese Cohort: Prospective Cohort Study"],"prefix":"10.2196","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6629-6954","authenticated-orcid":false,"given":"An Viet","family":"Tran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0843-1629","authenticated-orcid":false,"given":"Nguyen Khoi Quoc","family":"La","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3959-0194","authenticated-orcid":false,"given":"Van Anh Thi","family":"Phan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4623-7033","authenticated-orcid":false,"given":"Bao The","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6062-9228","authenticated-orcid":false,"given":"Hoa Thai","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6723-5304","authenticated-orcid":false,"given":"Nhung Hong Thi","family":"Thai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0917-1805","authenticated-orcid":false,"given":"Tho Anh Kieu","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"issue":"17","key":"R1","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","article-title":"Global burden of heart failure: a comprehensive and updated review of epidemiology","volume":"118","author":"Savarese","journal-title":"Cardiovasc Res"},{"issue":"34","key":"R2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000044060","article-title":"Enhancing quality of life and functional capacity in heart failure patients with iron deficiency: a regional cross-sectional study on intravenous iron therapy in Vietnam","volume":"104","author":"Doan","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"R3","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nrcardio.2015.14","article-title":"The vulnerable phase after hospitalization for heart failure","volume":"12","author":"Greene","journal-title":"Nat Rev Cardiol"},{"issue":"4","key":"R4","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1001\/jama.2012.216476","article-title":"Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia","volume":"309","author":"Dharmarajan","journal-title":"JAMA"},{"issue":"21","key":"R5","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1001\/jama.2010.748","article-title":"Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993-2006","volume":"303","author":"Bueno","journal-title":"JAMA"},{"issue":"2","key":"R6","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1001\/jamacardio.2016.3956","article-title":"Prediction of 30-day all-cause readmissions in patients hospitalized for heart failure: comparison of machine learning and other statistical approaches","volume":"2","author":"Frizzell","journal-title":"JAMA Cardiol"},{"issue":"18","key":"R7","doi-asserted-by":"publisher","first-page":"e895","DOI":"10.1161\/CIR.0000000000001063","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","journal-title":"Circulation"},{"issue":"10","key":"R8","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nrd2660","article-title":"The IL-33\/ST2 pathway: therapeutic target and novel biomarker","volume":"7","author":"Kakkar","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"R9","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jacc.2007.05.014","article-title":"Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study","volume":"50","author":"Januzzi","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"R10","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12123970","article-title":"Prognostic value of sST2 in heart failure","volume":"12","author":"Sciatti","journal-title":"J Clin Med"},{"issue":"11","key":"R11","doi-asserted-by":"publisher","DOI":"10.3390\/jcdd10110468","article-title":"Soluble ST2 in heart failure: a clinical role beyond B-type natriuretic peptide","volume":"10","author":"Riccardi","journal-title":"J Cardiovasc Dev Dis"},{"issue":"8","key":"R12","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1080\/00015385.2024.2406683","article-title":"Prognostic value of sst2 in long-term mortality in acute heart failure","volume":"79","author":"Matyar","journal-title":"Acta Cardiol"},{"issue":"1","key":"R13","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-021-01440-5","article-title":"Major adverse cardiovascular event definitions used in observational analysis of administrative databases: a systematic review","volume":"21","author":"Bosco","journal-title":"BMC Med Res Methodol"},{"issue":"3","key":"R14","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jchf.2022.07.006","article-title":"Smoking cessation reduces the risk of heart failure: a nationwide cohort study","volume":"11","author":"Yoo","journal-title":"JACC Heart Fail"},{"issue":"12","key":"R15","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1016\/j.cardfail.2024.04.003","article-title":"Alcohol consumption and progression of heart failure in those at risk for or with pre-heart failure","volume":"30","author":"Wong","journal-title":"J Card Fail"},{"issue":"1","key":"R16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"Lang","journal-title":"J Am Soc Echocardiogr"},{"issue":"9","key":"R17","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","journal-title":"Ann Intern Med"},{"issue":"1","key":"R18","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/EDE.0b013e3181c30fb2","article-title":"Assessing the performance of prediction models: a framework for traditional and novel measures","volume":"21","author":"Steyerberg","journal-title":"Epidemiology"},{"issue":"1","key":"R19","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-019-1466-7","article-title":"Calibration: the Achilles heel of predictive analytics","volume":"17","author":"Van Calster","journal-title":"BMC Med"},{"key":"R20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g7594","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement","volume":"350","author":"Collins","journal-title":"BMJ"},{"key":"R21","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-078378","article-title":"TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods","volume":"385","author":"Collins","journal-title":"BMJ"},{"issue":"7","key":"R22","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1002\/sim.7992","article-title":"Minimum sample size for developing a multivariable prediction model: PART II\u2014binary and time-to-event outcomes","volume":"38","author":"Riley","journal-title":"Stat Med"},{"issue":"1","key":"R23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/biomet\/80.1.27","article-title":"Bias reduction of maximum likelihood estimates","volume":"80","author":"Firth","journal-title":"Biometrika"},{"issue":"16","key":"R24","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1002\/sim.1047","article-title":"A solution to the problem of separation in logistic regression","volume":"21","author":"Heinze","journal-title":"Stat Med"},{"issue":"6","key":"R25","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1177\/0272989X06295361","article-title":"Decision curve analysis: a novel method for evaluating prediction models","volume":"26","author":"Vickers","journal-title":"Med Decis Making"},{"issue":"3","key":"R26","doi-asserted-by":"publisher","first-page":"219","DOI":"10.11909\/j.issn.1671-5411.2021.03.009","article-title":"Heart failure in the elderly","volume":"18","author":"D\u00edez-Villanueva","journal-title":"J Geriatr Cardiol"},{"issue":"4","key":"R27","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/ejhf.2471","article-title":"Renal effects of guideline-directed medical therapies in heart failure: a consensus document from the Heart Failure Association of the European Society of Cardiology","volume":"24","author":"Mullens","journal-title":"Eur J Heart Fail"},{"issue":"17","key":"R28","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1016\/j.jacc.2019.08.1039","article-title":"Clinical and prognostic significance of sST2 in heart failure: JACC review topic of the week","volume":"74","author":"Aimo","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"R29","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s11596-024-2907-x","article-title":"Soluble ST2: a novel biomarker for diagnosis and prognosis of cardiovascular disease","volume":"44","author":"Feng","journal-title":"Curr Med Sci"},{"issue":"7","key":"R30","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1093\/eurjcn\/zvae031","article-title":"Machine learning-based 30-day readmission prediction models for patients with heart failure: a systematic review","volume":"23","author":"Yu","journal-title":"Eur J Cardiovasc Nurs"},{"issue":"17","key":"R31","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1001\/jama.2010.533","article-title":"Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure","volume":"303","author":"Hernandez","journal-title":"JAMA"},{"key":"R32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2025.09.020","article-title":"Optimizing pre-to-post discharge transition of care in patients hospitalized for heart failure\u2014part 3 of the international expert opinion series on acute heart failure management","author":"Salah","journal-title":"J Card Fail"}],"container-title":["JMIR Cardio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cardio.jmir.org\/2026\/1\/e97879","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T22:23:10Z","timestamp":1785536590000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardio.jmir.org\/2026\/1\/e97879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":32,"URL":"https:\/\/doi.org\/10.2196\/97879","relation":{},"ISSN":["2561-1011"],"issn-type":[{"value":"2561-1011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]},"article-number":"v10i17e97879"}}